By Prasenjit Das
The Indian pharmaceutical industry is about to undergo a profound transformation driven by AI (artificial intelligence) and ML (machine learning) in 2025. These two technologies will revolutionise drug discovery, development, manufacturing, and patient care. This advancement will propel the country to lead global pharmaceutical innovation.
Here are the key pharma areas that AI and ML will impact:
Sudarshan Jain, Secretary General Indian Pharmaceutical Alliance (IPA) said ‘’Indian pharma market is projected to reach $120-130 billion by 2030 which is $58 billion currently. ‘’Given the conducive policies and the advantage of demographic and digital talent, India will play a pivotal role in advancing global health for all in years to come’’.
“Additionally, the industry is set to make notable progress in areas such as CAR-T cell therapy, mRNA vaccines, and the development of complex molecules, which hold immense potential for driving future growth,” he added.
Jain stated, “A focus on research excellence and innovation will position India as a global hub for high-quality, affordable pharmaceuticals. Collaboration between policymakers, academia and industry stakeholders will address unmet medical needs, particularly in underserved regions,”